Background: There is a need for a critically evaluated reference method for thyroxine to provide an accuracy base to which routine methods can be traceable. We describe a candidate reference method involving isotope-dilution coupled with liquid chromatography/ mass spectrometry. Methods: An isotopically labeled internal standard, thyroxine-d 5 , was added to serum, followed by equilibration, protein precipitation, and ethyl acetate and solid-phase extractions to prepare samples for liquid chromatography-mass spectrometry electrospray ionization (LC/MS-ESI) analysis. For separation, a Zorbax Eclipse XDB-C 18 column was used with a mobile phase consisting of 1 mL/L acetic acid in acetonitrile-water 
Various ID gas chromatography-mass spectrometry methods have been published for the determination of T 4 in serum (2) (3) (4) (5) . These methods involve liquid-liquid extraction or purification by multiple LC columns, and a two-step derivatization of thyroxine before gas chromatographic-mass spectrometric analysis. The resulting derivatives have very high relative molecular weights (ϳ1000) and are difficult to measure by gas chromatography. Recent developments of highly sensitive LC/MS instrumentation with robust interfaces such as electrospray or atmospheric pressure chemical ionization make it possible to develop highly reproducible, selective, and sensitive LC/MS methods for low-concentration analytes (6, 7 ) . We developed a solid-phase extraction (SPE) procedure that uses mixed-mode retention mechanisms of reversed-phase and ion-exchange to isolate thyroxine from serum. Because of the specificity and selectivity of the SPE extraction, the extract produced was clean with no interference at ions monitored by LC/MS. The twostep liquid-liquid extraction used by the earlier LC-tandem MS proposed reference method (6 ) was not as selective as the SPE used here, and thus tandem MS has been needed to provide interference-free ion chromatograms. In addition to positive-ion measurement for thyroxine, we also developed a negative-ion measurement method with a LC separation using a column stable at the high pH necessary for generation of sufficient negative ions for good sensitivity.
This LC/MS-ESI method was applied to the determination of thyroxine in samples of frozen serum pools. The method was evaluated by measuring thyroxine in both positive and negative modes. The LC/MS-ESI method was compared with routine clinical methods.
Materials and Methods materials
The l-thyroxine reference compound used for this work was obtained from Aldrich. The impurities in this thyroxine material were evaluated at NIST by LC/MS-ESI, LC with ultraviolet detection, and direct-probe MS and moisture content by Karl Fischer titration. Appropriate corrections were made for impurities and moisture content. A stable deuterium-labeled internal standard, l-thyrox-
, was synthesized at NIST by the oxidative coupling of 4-hydroxy-3,5-diiodophenylpyruvic acid and diiodo-tyrosine-d 5 as described by Ramsden and Farmer (8 ) 
preparation of calibrators
Two independently weighed stock solutions of thyroxine were prepared. Approximately 5 mg of the thyroxine reference compound for each stock solution was accurately weighed on an analytical balance (Mettler ME22; a readability of 1 g) and dissolved in 20 mL of methanol containing several drops of 1 mol/L hydrochloric acid in a 100-mL volumetric flask. The balance was calibrated and accurate to 1 g. After complete dissolution of the thyroxine, the flask was filled to the mark with methanol. Immediately after preparation of the stock solutions, a working solution was prepared from each stock by diluting 5.0 mL in 0.05 mol/L Na 2 HPO 4 buffer (pH 11.6) in a 100-mL volumetric flask containing 5 mg of diiodotyrosine as a protective carrier substance. The final concentrations of thyroxine in the working solutions were ϳ2.5 mg/L. A solution of isotopically labeled internal standard, thyroxine-d 5, at a concentration of ϳ2.5 mg/L was prepared in the same way as the unlabeled thyroxine. The two working solutions of thyroxine were cross-checked against each other by LC/MS and were within 0.5% of each other.
Thyroxine-d 5 was added to two aliquots of each working solution of thyroxine, yielding four calibrators with mass ratios of unlabeled to labeled compound ranging from 0.68 to 1.32. The mixtures were diluted with a solvent consisting of 10 mL/L acetic acid in acetonitrilewater (32:68 by volume) to a thyroxine concentration ϳ0.25 mg/L for LC/MS analysis. The stock solution was aliquoted with a Rainin EDP-2 motorized pipette. The volumes were calibrated by weighing.
sample preparation
Samples of frozen serum pools were prepared in three different sets (each set on a different day), each set consisting of two vials each of three concentrations: 50, 110, and 168 g/L for concentrations 1, 2, and 3, respectively. Duplicate 3.0-mL aliquots were taken from each vial for sample work-ups. Each aliquot was placed in a 50-mL Teflon centrifuge tube containing 5 g of diiodotyrosine as a protective carrier substance, and an appropriate amount of thyroxine-d 5 was added to give an ϳ1:1 ratio of analyte to internal standard. Each sample was acidified to pH 2 with 1 mol/L hydrochloric acid and equilibrated at 37°C for 2 h.
After equilibration, the mixture was deproteinized with 5 mL of 150 g/L trichloroacetic acid in an ice bath for 30 min. The thyroxine was then extracted from the deproteinized sample with 5 mL of ethyl acetate (10 ) . Each tube was shaken vigorously for 10 min on a mechanical shaker to allow complete mixing. After centrifugation of the tube for 10 min at 2000g, the upper ethyl acetate layer was transferred to another 50-mL Teflon tube containing 5 g of diiodotyrosine. Ethyl acetate extraction was repeated twice more with 4 mL and 3 mL of ethyl acetate, respectively. The combined ethyl acetate extract was reduced to ϳ0.5 mL under nitrogen at 40°C. The thyroxine was then further isolated from the serum matrix by Bond-Elut Certify SPE. To this concentrated extract was added 1 mL of methanol and 4 mL of 0.01 mol/L hydrochloric acid, and the pH was adjusted to 1.5 Ϯ 0.5 with 3 mol/L potassium hydroxide. Each sample was loaded at a rate of 3-4 mL/min on a cartridge previously conditioned by wetting with 6 mL of methylene chloride-2-propanol (75:25 by volume), 6 mL of methanol, and 6 mL of 0.01 mol/L hydrochloric acid. The cartridge was then washed sequentially with 10 mL of water, 10 mL of 0.1 mol/L hydrochloric acid, 20 mL of methanol, and 10 mL of methylene chloride-2-propanol (75:25 by volume). The thyroxine was eluted from the cartridge with 5 mL of methylene chloride-2-propanol-ammonium hydroxide (70:26.5:3.5 by volume). The eluate was dried under nitrogen at 40°C and reconstituted with a solvent consisting of 10 mL/L acetic acid in acetonitrile-water (32:68 by volume) to a final concentration of 0.25 mg/L thyroxine for LC/MS analysis.
125 I-labeled l-thyroxine was used as a tracer to evaluate the recovery of thyroxine from serum with this extraction method.
equilibration Vials of frozen serum samples were combined, and six 3.0-mL aliquots were taken for the equilibration study. Each aliquot was equilibrated at 37°C for various times (0.5, 1, 1.5, 2, 3, and 4 h). The samples were processed as described above for positive-ion measurement.
recovery of added thyroxine
Vials of concentration 1 frozen serum samples were combined, and twelve 3.0-mL aliquots were taken for a test for the accuracy of the method. Unlabeled thyroxine was added to 9 of the 12 aliquots, 3 each with 56.7, 85.1, and 113.4 g/L thyroxine. No thyroxine was added to the other three aliquots. A given amount of thyroxine-d 5 was added to each aliquot, and the aliquots were then processed as described above for positive-ion measurement.
lc/ms-esi analysis
Analysis was performed on a Hewlett Packard 1100 Series LC/MSD from Agilent Technologies with an ESI interface. An autosampler was used. The flow rate was 0.3 mL/min. The nitrogen drying gas temperature was set at 350°C, and the flow was 12 L/min. The nebulizer pressure was set at 172 kPa (25 psi), Vcap at 3500 V, and fragmentor at 100 V.
[M ϩ H] ϩ ions at m/z 778 and 783 for thyroxine and thyroxine-d 5 were monitored for positive ions. A Zorbax Eclipse XDB-C 18 column with double endcapping was used to provide good peak shape for thyroxine. Aliquots (20 L) of calibrators or sample extracts (ϳ5 ng of thyroxine) were analyzed by LC with an isocratic mobile phase consisting of 1 mL/L acetic acid in acetonitrilewater (32:68 by volume).
[ 
measurement protocol
The following measurement protocol was used for LC/MS analysis. For positive-ion measurements, four samples from one concentration of a given set were analyzed as a group. For negative-ion measurements, six samples from all three concentrations of a given set were analyzed as a group. For each group of samples, a single analysis of each of the four calibrators was run first. Subsequently, duplicate analyses of each sample were run. Finally, the four calibrators were run again in reverse order. By combining the data of calibrators run before and after the samples, we calculated a composite linear regression, which was used to convert the measured intensity ratios of analyte to mass ratios. The mass ratios were then used along with the amounts of the internal standard added to calculate analyte concentrations.
Results and Discussion extraction
The combination of deproteinization and liquid-liquid and solid-phase extractions produced a clean extract with no interference detected at the ions monitored.
125 I-labeled l-thyroxine was used as a tracer to evaluate the extraction procedures.
The overall recovery of thyroxine from the serum with this extraction method was ϳ74%. As long as equilibration is complete, as discussed below, relative recoveries of the native thyroxine and thyroxine-d 5 internal standard should be equal. Therefore, the absolute recoveries are not critical because it is the ratio of unlabeled to labeled thyroxine that is measured.
Experiments were performed to support a lack of ion suppression. The extracts from two kinds of biologic matrices, human serum albumin (Sigma No. A3782) and bovine serum albumin (Standard Reference Material 927c), were prepared, and known amounts of thyroxine were added. The response of thyroxine in the extracts was compared with the matching concentration of thyroxine in the absence of extracts. No differences in responses were found (within 0.3%), demonstrating that there is no evidence of ion suppression.
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Complete equilibration of thyroxine in serum with the added internal standard is necessary for accurate measurement. The time required for thyroxine to be liberated from its protein binding and then equilibrated with the internal standard, thyroxine-d5, was investigated. It was found that the equilibration was complete within 30 min at 37°C, and the ratio of thyroxine to thyroxine-d 5 was unchanged for up to 4 h. Two hours was the time chosen for equilibration.
recovery of added thyroxine
The recovery data for the added thyroxine are listed in Table 1 . The mean concentration of endogenous thyroxine was 49.4 g/L. The amounts of thyroxine recovered and added were in very good agreement for all three concentrations, with mean recoveries of 99.5%, 100.6%, and 99.5% for 56.7, 85.1, and 113.4 g/L of added thyroxine, respectively.
serum results
The LC/MS-ESI method for the determination of thyroxine was applied to samples of frozen serum pools. Samples were prepared and analyzed in three different sets, each set consisting of three concentrations of thyroxine. The results are shown in Table 2 for positive ions and  Table 3 for negative ions. Excellent reproducibility was obtained for all three concentrations, with within-set CVs of 0.2-1.0% and between-set CVs of 0.2-0.6%. Excellent linearity was also obtained, with the correlation coefficients (r) for all linear regression lines (measured intensity ratios vs mass ratios) ranging from 0.999 to 1.000. A linear regression line was generated for each group of samples. A typical regression line was: y ϭ Ϫ0.0654 ϩ 1.2206x (r ϭ 0.9998; SE ϭ 0.0070; n ϭ 8). The statistical analysis, as given in Table 4 , showed that positive-and negative-ion measurements were in good agreement with a mean difference of 0.45%, demonstrating that there is no significant undetected bias. The detection limits (at a signal-tonoise ratio of ϳ3 to 5) were 30 and 20 pg for positive and negative ions, respectively. Single-ion chromatograms for thyroxine and thyroxine-d 5 
statistical analysis
The overall uncertainty in the measurements includes the measurement repeatability (type A) and other factors Table 2 . Positive-ion LC/MS-ESI measurements of thyroxine in serum. (type B) that include the bias between the two measurement approaches and the purity of the reference compound. The calculation of the uncertainty is shown in Table 4 . The standard deviations from the positive-and negative-ion measurements were quite similar, thus contributing about equally to the uncertainty overall. As with most high-precision ID/MS measurements, within-set variability was small compared with set-to-set variability for most cases, as shown by analyses of variance. Consequently, for each concentration under each measurement condition, n was taken as 3 (the number of sets). The data from the positive-and negative-ion measurements suggest that there may be a small bias between the results from the two types of measurements. The mean difference was 0.45% for the negative-ion results vs the positive-ion results. It is possible that there was a trend toward smaller differences at higher concentrations, but the differences for individual samples were scattered sufficiently to preclude any definitive conclusions about biases between the two types of measurements. Therefore, for the purpose of calculating the uncertainty, the mean difference was used. The reference compound, the unlabeled thyroxine calibrator, was evaluated for purity. The estimated purity with its 95% confidence interval, based on results from multiple techniques plus an allowance for undetected impurities, was 98.7% Ϯ 0.4%. This uncertainty in the purity was included in determining the overall uncertainty in the measurements.
comparison with routine clinical methods
The results obtained by the LC/MS-ESI method and the mean value of the routine clinical methods [ϳ2000 laboratories from College of American Pathologists (CAP) surveys] are compared in Table 5 , which shows that the relative standard deviations are Ն10% for the composite results from many routine clinical methods in the CAP survey for the three concentrations measured in this study, demonstrating that there is considerable variability among the clinical methods in use today. The results from the candidate reference method were within 1 SD of the composite means for these same materials in the CAP survey, although it appears that the clinical method means may be biased high by 4 -5 g/L across the concentrations. If this is true, then some of the methods in routine use may be biased high by up to 20% at the low concentrations.
In conclusion, this well-characterized LC/MS-ESI method for total serum thyroxine, with its theoretically sound approach, demonstrated good accuracy and precision and low susceptibility to interferences, which qualifies it as a candidate reference method. Use of this reference method as an accuracy base may reduce the apparent biases in routine methods along with the high interlaboratory imprecision. NIST is planning to develop a serum-based Standard Reference Material for thyroxine. Because there is considerable interest in the measurement of free (non-protein-bound) thyroxine, research will be conducted into the isolation of free thyroxine from bound thyroxine. If a scientifically sound and reproducible approach to this isolation can be found, this method will be applied to the measurement of free thyroxine. Methods for thyroxine determination by ID/MS are under consideration for comparison studies involving national metrologic institutes from around the world.
